Navigation Links
Largest ever study of childhood ALL shows improving survival
Date:3/14/2012

A 21,626-person study published today in the Journal of Clinical Oncology found that the five-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL), the most common childhood cancer, improved from 83.7 percent in those diagnosed during the years 1990-1994, to 90.4 percent for those diagnosed in the years 2000-2005.

"The improved survival is due to using existing drugs better, not because of the introduction of new drugs. We're indebted to all the families who choose to join these clinical trials, allowing us to optimize these combinations," says Stephen Hunger, MD, investigator at the University of Colorado Cancer Center, professor of pediatrics at the University of Colorado School of Medicine, and director of the Center for Cancer and Blood Disorders at Children's Hospital Colorado, the study's lead author.

Data included all patients aged 0-22 years who received treatment on a Children's Oncology Group clinical trial, between 1990 and 2005. These patients represented an estimated 55.8 percent of ALL cases diagnosed in the United States during this period.

"I wonder how much more we could improve therapy for, say, breast cancer if half of all women with that disease were enrolled in clinical trials," Hunger says.

Additional findings include significant improvements in survival for African American patients with ALL, which narrowed the racial survival gap. Also, the only group in which survival didn't increase during this period was infants less than one year old, whose decrease in death from leukemia relapse was offset by an increase in treatment-related mortality.

"In early 1960s this disease was incurable," Hunger says. "Then in the late 1960s, the cure rate was 10 percent. Now almost 90 percent of children and adolescents diagnosed with ALL will be cured. Still, a 90-percent survival rate is little consolation to the 10 percent of families whose child doesn't survive. Ther
'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related medicine news :

1. An invitation to Europes largest forum on breast cancer
2. Reserve your place at the largest bone event in Europe
3. NDAR federation creates largest source of autism research data to date
4. Nations largest federation of biological and biomedical organizations welcomes 2 new members
5. Save the date: National meeting of the worlds largest scientific society
6. Unvaccinated Kids Behind Largest U.S. Measles Outbreak in Years: Study
7. Largest global childhood pneumonia etiology study launched
8. Worlds largest meeting of ear, nose and throat doctors
9. Largest Ob/Gyn Group Backs Annual Mammograms in 40s
10. TEMLA shows higher diagnostic yield than EBUS or EUS in largest reported series to date
11. Dubai to host largest clinical bone meeting in the Middle East and Africa region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 As concerns about ... power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) in gynecological surgeries ... detailing the continued use of uterine morcellation by ... specifically discouraged these procedures. According to The Wall ... cancer risks associated with power morcellators are overblown, ...
(Date:9/22/2014)... CareFlight Air & Mobile Services ... new AS365 N3+ Dauphin, the latest version of Airbus ... is based at Miami Valley Hospital in ... medical transport helicopters. , “We have a lot of ... Vice President, Emergency, Trauma, and CareFlight. “We’ve been operating ...
(Date:9/22/2014)... Diego CA (PRWEB) September 22, 2014 ... significantly expand its work to equip women around the ... on poverty. Through the Women Empowered (WE) Initiative ... will now join community-led groups to pool their savings, ... , “Women are the solution to ending poverty in ...
(Date:9/22/2014)... September 22, 2014 The New York ... of Surgery at the Icahn School of Medicine at ... York Group for Plastic Surgery gives residents of New ... a team of world-renowned plastic surgeons performing innovative reconstructive ... Salzberg, MD, who led NYGPS, was named the Director ...
(Date:9/22/2014)... WHO: LiveOps, Inc., the global leader ... , WHAT: The 10th annual Customer Response Summit ... the connected consumer. Constant change in technology and ... and opportunities for customer experience executives. The Summit ... network and learn from fellow attendees, speakers and ...
Breaking Medicine News(10 mins):Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 3Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 2Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 3Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 3Health News:LiveOps To Lead Panel Discussion At Customer Response Summit Memphis 2
... YORK, Oct. 8 "Fluoridation of drinking,water is scientifically ... initiative or program," says the Canadian Association of Physicians,for ... CAPE is Canada,s leading voice on environmental health issues., ... fluoridation of public,drinking water in several communities in Alberta, ...
... New interim guidance,that outlines how to become a ... U.S. Department of Health and Human Services., ... Safety Act),authorized the creation of PSOs to improve ... patient safety events. By providing both privilege,and confidentiality, ...
... appears to sustain insulin production in the newly diagnosed. ... have developed a vaccine that may change the way ... diagnosed with type 1 diabetes. , "By a very ... save [a person,s] own insulin secretion, which may be ...
... N.J., Oct. 8 Quest Diagnostics,Incorporated (NYSE: DGX ... services, announced today that its third-quarter,2008 results will be ... and that it will hold its quarterly conference call ... ET on that day., The public may access ...
... The following statement,of Matthew L. Myers was released today ... reports, R.J. Reynolds has announced plans to,test-market three new ... "fresh" and "mellow" flavors and have slick, colorful,packaging similar ... Orbs,these new products also carry the name of RJR,s ...
... HOLE, MA Osamu Shimomura, a senior scientist emeritus ... has been awarded the Nobel Prize in Chemistry for ... the most important tools in contemporary science and medicine ... Shimomura shares the prize, which was announced early today ...
Cached Medicine News:Health News:Physicians' Group Rejects Fluoridation 2Health News:HHS Issues Interim Guidance for Patient Safety Organizations 2Health News:New Vaccine May Help Type 1 Diabetics in Future 2Health News:New Vaccine May Help Type 1 Diabetics in Future 3Health News:Quest Diagnostics to Release Third Quarter 2008 Financial Results 2Health News:R.J. Reynolds' New Smokeless Products Will Appeal to Children and Show Need for FDA Regulation of Tobacco Products 2Health News:MBL scientist Osamu Shimomura wins Nobel Prize for discovery of green fluorescent protein 2Health News:MBL scientist Osamu Shimomura wins Nobel Prize for discovery of green fluorescent protein 3
(Date:9/22/2014)... DIEGO , Sept. 22, 2014  Aethlon ... targeted therapeutic devices to address infectious disease, cancer ... Defense Advanced Research Projects Agency (DARPA) has informed ... option to proceed with year four of a ... Aethlon on September 30, 2011 under DARPA,s Dialysis-Like ...
(Date:9/22/2014)... Inc. (NYSE MKT: CUR) announced that Jonathan D. ... long-term follow up data on the Phase I trial ... of amyotrophic lateral sclerosis (ALS or Lou Gehrig,s ... Symposium on ALS of the Foundation Andre-Delambre, in ... not open to the public, covered data up to ...
(Date:9/22/2014)... CENTER VALLEY, Pa. , Sept. 22, 2014 ... and delivering innovative solutions for medical and surgical ... has reached a deal with Munich ... distributor of Kick ® Navigation. This agreement ... maintain distribution for cross-disciplinary U.S. sales and all ...
Breaking Medicine Technology:Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
... N.J. , May 19 ... CardioTec, the first and only conference dedicated to addressing ... event, sponsored by Medical Product Outsourcing magazine, ... issues through a specialized agenda and extraordinary lineup of ...
... May 18 Thoratec Corporation (Nasdaq: ... support therapies to save, support and restore failing hearts, ... early termination of the waiting period under the Hart-Scott-Rodino ... previously announced sale of International Technidyne Corporation (ITC) to ...
Cached Medicine Technology:Medical Product Outsourcing Magazine Announces the First Annual CardioTec Conference 2Medical Product Outsourcing Magazine Announces the First Annual CardioTec Conference 3Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation 2
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
DxRxValv contains tables and figures to summarize important clinical data and current professional society recommendations. This handy manual details precise, up-to-date information for diagnosis and...
... Dx/Rx: Coronary Thrombosis ... flowcharts which facilitate transformation ... protocols from static images ... support tools. Details precise, ...
Cardiology Intensive Board Review is geared specifically to candidates taking the Cardiovascular Boards and the Cardiovascular section of the Internal Medicine Boards....
Medicine Products: